Sign inGet started

Islam Khalid

Insider CIK 1701858 · FENC Director · PCSA Director · GANX Executive Chairman, Director · IMMU Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GANX Gain Therapeutics, Inc. A Award deriv2026-07-152026-07-1725,000— $025,000SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2026-06-102026-06-1025,000$8.70 $217.5K250,000SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2025-06-242025-06-2515,000— $015,000SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2025-06-032025-06-0425,000$7.88 $197.0K225,000SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2024-08-152024-08-1925,000$5.58 $139.5K200,000SEC↗
GANX Gain Therapeutics, Inc. P Buy2024-08-092024-08-1250,000$1.00 $50.0K50,000SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2024-06-242024-06-2615,000— $015,000SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise deriv2023-11-162023-11-1620,492$2.44 $50.0K175,000SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise deriv2023-11-162023-11-1650,000$1.13 $56.5K195,492SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise deriv2023-11-162023-11-1610,000$2.69 $26.9K245,492SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise deriv2023-11-162023-11-16133,333$2.31 $308.0K255,492SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise2023-11-162023-11-16133,333$2.31 $308.0K133,333SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise2023-11-162023-11-1610,000$2.69 $26.9K143,333SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise2023-11-162023-11-1620,492$2.44 $50.0K213,825SEC↗
FENC FENNEC PHARMACEUTICALS INC M Exercise2023-11-162023-11-1650,000$1.13 $56.5K193,333SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2023-06-232023-06-2610,500— $010,500SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2023-06-122023-06-1325,000— $0388,825SEC↗
GANX Gain Therapeutics, Inc. A Award deriv2022-09-202022-09-2210,500— $010,500SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2022-06-142022-06-1625,000— $025,000SEC↗
PCSA Processa Pharmaceuticals, A Award2022-03-312022-04-044,392— $072,486SEC↗
PCSA Processa Pharmaceuticals, A Award deriv2022-01-012022-04-1918,208— $018,208SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2021-06-292021-07-0125,000— $025,000SEC↗
IMMU IMMUNOMEDICS INC D To issuer deriv2020-10-232020-10-2352,614— $00SEC↗
IMMU IMMUNOMEDICS INC D To issuer deriv2020-10-232020-10-233,718— $00SEC↗
IMMU IMMUNOMEDICS INC D To issuer2020-10-232020-10-2313,516— $00SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2020-08-132020-08-1425,000— $025,000SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2020-06-182020-06-226,540— $06,540SEC↗
IMMU IMMUNOMEDICS INC A Award2020-06-182020-06-223,718— $017,234SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2019-06-182019-06-1925,000— $025,000SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2019-06-072019-06-1117,077— $017,077SEC↗
IMMU IMMUNOMEDICS INC A Award2019-06-072019-06-119,667— $013,516SEC↗
FENC FENNEC PHARMACEUTICALS INC A Award deriv2018-06-082018-06-1125,000— $025,000SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2018-04-022018-09-196,497— $06,497SEC↗
IMMU IMMUNOMEDICS INC A Award2018-04-022018-09-193,849— $03,849SEC↗
IMMU IMMUNOMEDICS INC A Award deriv2017-07-032017-07-0622,500— $022,500SEC↗